MedTrace Logo

Feasibility of BOTOX Injection on Improving Female Stress Urinary Incontinence

NCT04984317 · Status: SUSPENDED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2026-01-26

No results posted yet for this study

Summary

The purpose of this study is to assess the effect of onabotulinumtoxin A (BOTOX) injection into the detrusor muscle on increasing bladder compliance to reduce urinary leakage in women suffering from stress urinary incontinence (SUI).

Conditions

  • Stress Urinary Incontinence

Interventions

DRUG

onabotulinumtoxin A

One-time injection of 100U BOTOX

Sponsors & Collaborators

  • Allergan

    collaborator INDUSTRY

  • Northwell Health

    lead OTHER

Principal Investigators

  • Bilal Chughtai, MD · Weill Medical College of Cornell University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-02-14
Primary Completion
2026-12-31
Completion
2027-08-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04984317 on ClinicalTrials.gov